About Andrew Vaino
Form D filings for LB Pharmaceuticals from 2018 to 2024 list Andrew Vaino as executive officer.
Andrew Vaino first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Vaino in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Vaino works with at each company, as listed on that company's latest Form D.
LB Pharmaceuticals Inc. · Form D/A, Jan 10, 2024
RJ
Rajul Jain
Director
RN
Ran Nussbaum
Director
ZP
Zachary Prensky
Chief Executive Officer and director
RR
Robert Ruffolo
Director
AE
Anna Eramo
Executive officer
MP
Marc Panoff
Executive officer
RL
Rebecca Luse
Director
CY
Chen Yu
Director